Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data
Crossref DOI link: https://doi.org/10.1007/s00417-017-3681-2
Published Online: 2017-05-03
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Călugăru, Dan
Călugăru, Mihai
License valid from 2017-05-03
